Public shareholders via Hong Kong Stock Exchange
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$208.8B
Focus Areas
8
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Hansoh Pharma | $191.6B |
| WuXi Biologics | $17.2B |